Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05048355
Other study ID # CII2021050747
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 26, 2021
Est. completion date August 25, 2021

Study information

Verified date September 2021
Source Össur Ehf
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is conducted to evaluate the efficacy of the Power Knee Mainstream Dynamic compared to passive microprocessor-controlled knees (MPKs) regarding metabolic cost for high active transfemoral amputees.The test is of a single group repeated measures crossover design. The primary endpoint is the difference in MET/HRI-VO2 index between conditions. Subjects are measured on their prescribed device at visit 1, be fitted to the PKM which they wear as their primary prosthesis for one week before coming for visit 2 and being measured again on the PKM.


Description:

The metabolic cost of ambulation for individuals living with a lower limb amputation is significantly increased compared to able-bodied individuals. Individuals living with transfemoral amputation have shown up to 65% more exertion to generate half the ambulation speed of able-bodied individuals. The Power Knee Mainstream - Dynamic, was designed to provide powered swing dynamics to restore muscle activity and thereby attempting to mitigate this increase in metabolic cost that individuals living with TF amputation face. This study aims to evaluate this indirectly by measuring the heart rate during level ground walking on the Power Knee Mainstream - Dynamic compared to a passive MPK. Previous studies reported in the literature on previous versions of the Power Knee have shown that it provides active flexion and extension during walking2, 3, 4 and more symmetric gait5 compared to passive microprocessor-controlled knees (MPKs). By providing increased symmetry and active swing during level ground walking the knee is meant to lower the effort needed by the transfemoral prosthesis user to swing the leg forward and thereby lower the metabolic cost of level ground walking. This underpins the hypothesis being tested in this investigation, that the Power Knee Mainstream - Dynamic enables the user to walk with less metabolic cost compared to passive MPKs. A pilot investigation that was conducted with 5 subjects indicated that the Power Knee Mainstream - Dynamic enabled users to walk on level ground with less metabolic cost compared to passive MPKs, however the difference did not reach statistical significance. The same study procedure will be used in this study with sufficient sample size to achieve the statistical power needed, which was determined in a power analysis using data form the pilot study mentioned above. The primary objective of this study is to evaluate the efficacy of the investigational device compared to passive microprocessor-controlled knees (MPKs) regarding metabolic cost for high active transfemoral amputees. The test is of a single group repeated measures crossover design. Amputees are a small proportion of the general population. The primary endpoint is the difference in MET/HRI-VO2 index between conditions. Testing takes place in Össur HQ in Iceland as well as in Össur facility in Germany, the collective sample size in both sites is 20 subjects. Subjects are measured on their prescribed device at visit 1, be fitted to the PKM which they wear as their primary prosthesis for one week before coming for visit 2 and being measured again on the PKM. If a subject in the study is a current PKM user the procedure will apply in reverse and they will be provided with a Rheo knee to act as a comparator. Prior to the first visit subjects will be contacted via telephone and asked screening questions, if they fit the inclusion criteria they will be booked for study visit 1. They will receive instructions to consume no alcohol and perform no exercise for 24 hours before study visit 1, the same applies to visit 2. In addition, they will be instructed to consume no caffeine prior to the visits (same day) or drink the same amount before both visits and keep the same routine the 24 hours prior to visit 1 and 2 (breakfast, water/drink consumption etc.). During the one week follow up, subjects will be called via telephone to check the status of the device and the alignment and if there are issues identified they will be asked to come in to correct those.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date August 25, 2021
Est. primary completion date August 25, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 50Kg< body weight < 116Kg - Cognitive ability to understand all instructions and questionnaires in the study; - Higher active unilateral trans-femoral amputees - Allows for 37mm knee center height to dome of pyramid alignment to allow for symmetrical knee height to sound side - Willing and able to participate in the study and follow the protocol - Comfortable and stable socket fit - No socket issues/changes in the last 6 weeks - No residual limb pain affecting functional ability - Users with at least 6 months experience on a prosthesis Exclusion Criteria: - Hip disarticulation amputees - Bilateral amputees - Users with Osseointegrated prosthesis - Users with co-morbidities in the contra-lateral limb, which significantly affect their functional mobility - Users taking beta-adrenergic blocking agents (beta blockers) or other medication for heart rate control e.g. Verapamil & Digoxin.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Power Knee Mainstream Dynamic
Powered Microprocessor controlled prosthetic knee. The Power Knee Mainstream - Dynamic, was designed to provide powered swing dynamics to restore muscle activity and thereby attempting to mitigate this increase in metabolic cost that individuals living with TF amputation face.
Passive microprocessor controlled knee
Any passive microprocessor controlled prosthetic knee on the market

Locations

Country Name City State
Germany Össur Germany Bayreuth Bavaria
Iceland Össur HQ Reykjavík

Sponsors (1)

Lead Sponsor Collaborator
Össur Ehf

Countries where clinical trial is conducted

Germany,  Iceland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Metabolic cost MET/HRI-VO2 index 1 week
See also
  Status Clinical Trial Phase
Recruiting NCT03947450 - Autologous Volar Fibroblast Injection Into the Stump Site of Amputees Phase 2
Completed NCT04924036 - Qbrexza Cloths for Hyperhidrosis of Amputation Sites Phase 2
Recruiting NCT04839497 - Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees. Phase 2
Recruiting NCT04212299 - Transfemoral Socket Design and Muscle Function N/A
Completed NCT03733054 - Understanding Prosthetic Needs and Outcomes in Women Veterans With Amputation
Completed NCT03651830 - A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations N/A
Recruiting NCT04725006 - Sensory Responses to Dorsal Root Stimulation N/A
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT04936789 - Clinical Feasibility of the IMES Transradial Prosthesis N/A
Completed NCT01155024 - Clinical Evaluation of Direct Manufactured Prosthetic Sockets Phase 2
Completed NCT00663663 - Telephone Intervention for Pain Study (TIPS) N/A
Terminated NCT00778856 - Hand Transplantation for the Reconstruction of Below the Elbow Amputations N/A
Recruiting NCT00388752 - Acupuncture for the Treatment of Phantom Limb and Residual Limb Pain After Amputation Phase 1
Active, not recruiting NCT03374319 - Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations N/A
Completed NCT05542901 - Comparison of Joint Position Sense in Diabetic and Traumatic Transtibial Amputees N/A
Completed NCT05161364 - Kinetic Analysis Due to Foot Dysfunction
Recruiting NCT06194838 - Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees N/A
Completed NCT03570788 - HRQoL Among Patients Amputated Due to Peripheral Arterial Disease
Completed NCT05778799 - Physical Activity and Sports for People With Special Needs
Recruiting NCT04804150 - Daily Socket Comfort in Transtibial Amputee With an Active Vacuum Suspension System N/A